NPI Portal NPI Lookup & Verification

Type 2 · Organization ✓ Active NPI ✓ Valid NPI checksum

Renal Treatment Centers Mid Atlantic Inc

End-Stage Renal Disease (ESRD) Treatment Clinic/Center in Baltimore, MD · enumerated 2006 · authorized official Samuel Wey, Vp, Licensure & Certification.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1265503403

Verified

See something wrong? Report a correction

Registry record

Entity type Organization (Type 2)
Legal business name Renal Treatment Centers Mid Atlantic Inc
Other name <Unavail>
Practice address 4800 Seton Dr, Baltimore, MD, 21215
Fax (410) 585-0448
Enumeration date Nov 10, 2006
Last updated in NPPES May 13, 2026

Taxonomy & classification

261QE0700X End-Stage Renal Disease (ESRD) Treatment Clinic/Center Ambulatory Health Care Facilities · License E2653 (MD) Primary

Authorized official

Name Samuel Wey
Title Vp, Licensure & Certification

Other identifiers

Identifier Type State Issuer
4127536 00 Medicaid MD -

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

What type of organization is Renal Treatment Centers Mid Atlantic Inc?
Renal Treatment Centers Mid Atlantic Inc is registered in NPPES as a End-Stage Renal Disease (ESRD) Treatment Clinic/Center (its primary provider taxonomy).
What is a Type 2 NPI?
A Type 2 NPI identifies an organization (group practice, hospital, pharmacy, lab), while Type 1 NPIs identify individual providers. Organizations bill under their Type 2 NPI.

Providers at this address

Browse all →

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2026-05-13.